Figure 5.

Schematic ion channel with potential sites for drug modulation of function and the associated contributions to Δ G total I II . 1, binding in the pore (active site) to block ion movement, which may be small, maybe zero; 2, binding to allosteric sites formed by the protein, which will contribute to ΔGproteinIII (e.g., Jackson, 1989); 3, binding to allosteric sites formed by the protein plus bilayer lipids, which will contribute both ΔGproteinIII and ΔGbilayerIII (e.g., Obi and Natesan, 2022), as well as the so-called residual exposure contribution ΔGresIII due to imperfects hydrophobic matching between membrane proteins and their host bilayer (Mondal et al., 2011); 4, non-specific binding/enrichment at the protein/bilayer boundary, which will contribute to ΔGbilayerIII and maybe also ΔGresIII; and 5, partitioning into the bilayer/solution interface to alter bulk bilayer properties, which will contribute to ΔGbilayerIII. After Andersen, 2008 and Herold et al., 2014; see also Urban, 2002.

or Create an Account

Close Modal
Close Modal